Free shipping on all orders over $ 500

WKYMVM acetate

Cat. No. M31297
WKYMVM acetate Structure
Size Price Availability Quantity
5mg USD 440  USD440 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

WKYMVM acetate is a potent agonist of the N-formyl peptide receptors FPR1 and FPRL1/2, and also activates a number of leukocyte effector functions such as chemotaxis, activation of complement receptor-3 and NADPH oxidase.

Chemical Information
CAS Number 187986-17-0 (free base)
Storage -20°C, protect from light, sealed
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Igor A Schepetkin, et al. Molecules. Neutrophil Immunomodulatory Activity of (-)-Borneol, a Major Component of Essential Oils Extracted from Grindelia squarrosa

[2] Jonas Mårtensson, et al. J Leukoc Biol. Neutrophil priming that turns natural FFA2R agonists into potent activators of the superoxide generating NADPH-oxidase

[3] Igor A Schepetkin, et al. Biochem Pharmacol. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones

[4] Natalia Mossberg, et al. J Inflamm (Lond). Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome

[5] Natalia Mossberg, et al. J Neuroimmunol. Oxygen radical production in leukocytes and disease severity in multiple sclerosis

Related FPR Products
Ac9-25

Ac9-25, a N-terminal peptide of Annexin I, acts as a formyl peptide receptor (FPR) agonist and activates the neutrophil NADPH oxidase through FPR.

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist.

WKYMVM-NH2 TFA

WKYMVM-NH2 TFA is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist, also activates several leukocyte effector functions.

{Boc}-Phe-Leu-Phe-Leu-Phe

{Boc}-Phe-Leu-Phe-Leu-Phe ({Boc}-FLFLF) is a formyl peptide receptor (FPR) family antagonist that preferentially inhibits activity triggered through the formyl peptide receptor.

WKYMVM

WKYMVM is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist, also activates several leukocyte effector functions such as chemotaxis, mobilization of complement receptor-3, and activation of the NADPH oxidase.

  Catalog
Abmole Inhibitor Catalog




Keywords: WKYMVM acetate supplier, FPR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.